May 2025 - Pullan's Pieces #214
Linda: Fosun Snapshot
Kristine: Biotech Innovators as First-Time Launchers
Eric: Translational research
Trevor: Forecasted Fundamentals Looking Good
April 2025- Pullan's Pieces #213
Linda: Shift in deal stage?
Kristine: AI in Biotech and Pharma
Eric: More on AI
Trevor: Head and shoulders?
March 2025- Pullan's Pieces #212
Linda: Big pharma deals in 2025?
Linda: Big pharma unprecedented targets in CV, CNS, metabolic
Kristine: ADC Trends
Trevor: Soft landing optimism
February 2025 - Pullan's Pieces #211
Linda: Rare disease landscape
Linda: RNA binding proteins
Kristine: China Biotech
Trevor: The money-spending business
January 2025 - Pullan's Pieces #210
Linda: Amgen- an evolving company
Kristine: Anti-PD1xVEGF opportunity
Trevor: Seed to series A
We use cookies to analyze website traffic and optimize your website experience. By accepting our use of cookies, your data will be aggregated with all other user data.